On June 22, 2022, the Switzerland government announced the amendment to the Swiss Narcotics Act, which eases the ban on medical cannabis. This makes it easier for patients to use cannabis-based medicines.
As of August 1st, 2022, patients will be able to use cannabis-based medicines for therapeutic purposes without permission from the Federal Office of Public Health (FOPH). Although, cannabis for entertainment or other uses is still illegal.